# SeaStar Medical Holding Corp (ICU) · Edgar & Edgarette company card

> SeaStar Medical Holding (ICU) grew revenue 814% in FY2025 to $1 million, operating margin -987% against a 1.2% median for surgical & medical instruments & apparatus, equity 73.6% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1831868 · fiscal year ended 2025-12-31 · 3 audited years read · [page](https://www.pops4.com/boards/company/ICU) · [JSON](https://www.pops4.com/boards/company/ICU.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $1M |
| Revenue growth, 1 year | 814.1% |
| Revenue growth per year | — |
| Operating margin | -986.6% (prior year -13216.3%) |
| Net margin | -984.6% |
| Operating cash flow | −$14M |
| Capital spending | — |
| Free cash flow | — |
| Cash | — |
| Long-term debt | — |
| Total assets | $14M |
| Total equity | $10M |
| Equity ÷ assets | 73.6% |
| Return on equity | -116.6% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: -33.23 (distress zone)
- Piotroski F: 5 of 9 (middling)
- Health Harbor boat: Old boat · three warning signs · operating cash flow was negative; operating loss: a margin of -986.6% in FY2025; revenue is hard to predict: its 80% range is ±28%

## Edgarette's reading

Exposure: revenue $1.2M (FY2025). Experience: revenue up 814.1% on the year; operating margin -986.6%, up from -13216.3%. Soundness: equity 73.6% of assets, return on equity -116.6%. Credibility: 3 audited years, moderate weight. Range: 80% of past cases like this landed between $8.3M and $14.9M next year (method v3, set from 749 SEC company-years; on a year the method never saw, 83% landed inside). A statistical range, not company guidance. Against peers (60 filers, $50M+ revenue, surgical & medical instruments & apparatus): operating margin -986.6% against a 1.2% median; growth 814.1% against 11.6%.

Range logged 2026-10-06, receipt fd61cc9678af8bad, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 5.02 Director or officer change: 2, latest 2026-07-01 ([filing](https://www.sec.gov/Archives/edgar/data/1831868/000143774926022278/0001437749-26-022278-index.htm))

## Recent filings

- 10-Q · filed 2026-11-12 · [filing](https://www.sec.gov/Archives/edgar/data/1831868/000143774926036392/0001437749-26-036392-index.htm)
- 8-K · filed 2026-11-12 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1831868/000143774926036383/0001437749-26-036383-index.htm)
- 8-K · filed 2026-11-03 · 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1831868/000143774926034531/0001437749-26-034531-index.htm)
- 8-K · filed 2026-10-05 · 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities; 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1831868/000143774926032035/0001437749-26-032035-index.htm)
- 10-Q · filed 2026-08-12 · [filing](https://www.sec.gov/Archives/edgar/data/1831868/000143774926027353/0001437749-26-027353-index.htm)
- 8-K · filed 2026-08-12 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1831868/000143774926027314/0001437749-26-027314-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001831868.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1831868

## Cite

POPS4, Edgar & Edgarette: SeaStar Medical Holding Corp (ICU) company card, from the company's own SEC filings, accessed 2026-11-19, https://www.pops4.com/boards/company/ICU. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.

